14.59
price up icon7.44%   1.01
after-market After Hours: 14.59
loading
Optimizerx Corp stock is traded at $14.59, with a volume of 258.22K. It is up +7.44% in the last 24 hours and down -26.46% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$13.58
Open:
$13.58
24h Volume:
258.22K
Relative Volume:
0.78
Market Cap:
$271.97M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-18.24
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-3.89%
1M Performance:
-26.46%
6M Performance:
+25.67%
1Y Performance:
+224.94%
1-Day Range:
Value
$13.58
$14.94
1-Week Range:
Value
$13.57
$15.10
52-Week Range:
Value
$3.9914
$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name
Name
Optimizerx Corp
Name
Phone
248-651-6558
Name
Address
260 CHARLES STREET, WALTHAM, MI
Name
Employee
129
Name
Twitter
@OpRxTweets
Name
Next Earnings Date
2025-03-12
Name
Latest SEC Filings
Name
OPRX's Discussions on Twitter

Compare OPRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
OPRX
Optimizerx Corp
14.59 253.14M 62.81M -13.75M 153.00K -0.80
Health Information Services icon
VEEV
Veeva Systems Inc
244.06 44.34B 2.97B 809.93M 1.33B 4.8743
Health Information Services icon
TEM
Tempus Ai Inc
70.29 11.69B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
101.91 8.68B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
50.42 8.74B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
35.74 6.66B 906.14M -52.62M 89.62M -0.3621

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Dec-20-24 Initiated Stephens Equal-Weight
Jul-25-24 Resumed B. Riley Securities Buy
Apr-04-24 Initiated JMP Securities Mkt Outperform
Jan-03-24 Initiated Barclays Equal Weight
Feb-02-23 Resumed B. Riley Securities Buy
Nov-01-22 Initiated Stifel Buy
Jul-15-22 Initiated SVB Leerink Outperform
Oct-18-21 Resumed B. Riley Securities Buy
Apr-13-21 Initiated RBC Capital Mkts Outperform
Jan-03-19 Initiated William Blair Outperform
View All

Optimizerx Corp Stock (OPRX) Latest News

pulisher
03:55 AM

Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - Defense World

03:55 AM
pulisher
01:40 AM

Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com

01:40 AM
pulisher
Nov 20, 2025

P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat

Nov 18, 2025
pulisher
Nov 18, 2025

OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - Nasdaq

Nov 17, 2025
pulisher
Nov 17, 2025

OptimizeRx (OPRX) Analyst Rating Update: Stephens & Co. Lowers P - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX - MarketBeat

Nov 17, 2025
pulisher
Nov 17, 2025

When is the best time to exit OptimizeRx Corporation2025 Market Sentiment & Safe Entry Zone Tips - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Published on: 2025-11-16 12:30:34 - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Will OptimizeRx Corporation stock maintain momentum in 20252025 Valuation Update & AI Powered Market Trend Analysis - newser.com

Nov 15, 2025
pulisher
Nov 10, 2025

Can a trend reversal in OptimizeRx Corporation lead to recoveryJuly 2025 Outlook & Reliable Intraday Trade Plans - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript - Yahoo Finance

Nov 10, 2025
pulisher
Nov 09, 2025

OptimizeRx (NASDAQ:OPRX) Issues Earnings Results, Beats Expectations By $0.17 EPS - MarketBeat

Nov 09, 2025
pulisher
Nov 09, 2025

OptimizeRx (NASDAQ:OPRX) Raised to Strong-Buy at Wall Street Zen - MarketBeat

Nov 09, 2025
pulisher
Nov 09, 2025

ETFs Investing in OptimizeRx Corporation Stocks - TradingView

Nov 09, 2025
pulisher
Nov 09, 2025

OptimizeRx Corporation (NASDAQ:OPRX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 09, 2025
pulisher
Nov 08, 2025

Citizens Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN

Nov 08, 2025
pulisher
Nov 08, 2025

OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat

Nov 08, 2025
pulisher
Nov 08, 2025

How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts - Yahoo Finance

Nov 08, 2025
pulisher
Nov 08, 2025

OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates - sharewise.com

Nov 08, 2025
pulisher
Nov 07, 2025

[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan

Nov 07, 2025
pulisher
Nov 07, 2025

[10-Q] OptimizeRx Corp Quarterly Earnings Report | OPRX SEC FilingForm 10-Q - Stock Titan

Nov 07, 2025
pulisher
Nov 07, 2025

OptimizeRx (OPRX) Analyst Rating Update: Price Target Raised to $24.00 | OPRX Stock News - GuruFocus

Nov 07, 2025
pulisher
Nov 07, 2025

OptimizeRx Delivers Big Earnings Beat And Raises Outlook Again - Finimize

Nov 07, 2025
pulisher
Nov 07, 2025

OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... By GuruFocus - Investing.com Canada

Nov 07, 2025
pulisher
Nov 07, 2025

OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... - Yahoo Finance

Nov 07, 2025
pulisher
Nov 06, 2025

Vanguard Group Inc's Strategic Acquisition of OptimizeRx Corp Sh - GuruFocus

Nov 06, 2025
pulisher
Nov 06, 2025

Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations - Investing.com

Nov 06, 2025
pulisher
Nov 06, 2025

OPTIMIZERx earnings beat by $0.16, revenue topped estimates - Investing.com

Nov 06, 2025
pulisher
Nov 06, 2025

OptimizeRx Corp reports results for the quarter ended September 30Earnings Summary - TradingView

Nov 06, 2025
pulisher
Nov 06, 2025

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance - The Manila Times

Nov 06, 2025
pulisher
Nov 06, 2025

[8-K] OptimizeRx Corp Reports Material Event | OPRX SEC FilingForm 8-K - Stock Titan

Nov 06, 2025
pulisher
Nov 06, 2025

OptimizeRx (Nasdaq: OPRX) raises full-year outlook to $105M-$109M; updates EBITDA view - Stock Titan

Nov 06, 2025
pulisher
Nov 06, 2025

Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com

Nov 06, 2025

Optimizerx Corp Stock (OPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Optimizerx Corp Stock (OPRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Option Exercise
0.00
6,649
0
190,536
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Sale
18.75
1,620
30,375
188,916
Stelmakh Edward
Chief Finance & Strat Officer
Oct 03 '25
Option Exercise
0.00
16,623
0
127,387
Besch Doug
Chief Product & Tech Officer
Oct 03 '25
Option Exercise
0.00
3,325
0
70,555
Spangler Patrick D
Director
Aug 28 '25
Sale
17.49
11,120
194,489
44,215
health_information_services TXG
$18.34
price up icon 11.42%
$28.17
price down icon 0.04%
$30.85
price up icon 11.49%
$23.74
price up icon 5.28%
$34.59
price up icon 5.59%
health_information_services WAY
$35.74
price up icon 2.73%
Cap:     |  Volume (24h):